The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis

Launched by HACETTEPE UNIVERSITY · Oct 12, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how bone mineral density, which is a measure of the strength and health of bones, is affected in adults with cystic fibrosis. The researchers want to understand if there are any changes in bone density among patients aged 18 to 45 who have this condition. Cystic fibrosis is a genetic disease that mainly affects the lungs but can also impact other parts of the body, including the bones.

To participate in the study, individuals must be between 18 and 45 years old and have a diagnosis of cystic fibrosis. However, those who have had a fracture, spine surgery, or specific other medical issues in the past year are not eligible. If you join the trial, you will be closely monitored and may undergo various tests to assess your bone health. This study aims to gather important information that could lead to better care for people with cystic fibrosis, particularly regarding their bone health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged between 18-45 who were diagnosed with Cystic Fibrosis
• Exclusion Criteria:
• • In the last year, patients;
• • who had a fracture in any part of the patient's body
• • who had undergone spine surgery
• • who had an orthopedic, neurological or metastatic history in addition to Cystic Fibrosis